BioNTech to work with Terry Gou's foundation on cancer immun

Taipei, Dec. 17 (CNA) The YongLin Healthcare Foundation will partner with BioNTech to develop mRNA-based cancer immunotherapies, according to Terry Gou (郭台銘), founder of the foundation and manufacturing giant Hon Hai Precision Industry Co.

Related Keywords

Germany , Australia , Taiwan , Japan , Singapore , China , Taipei , T Ai Pei , Yonglin , Anhui , South Korea , National Taiwan University , Chinese , German , Frances Huang , Terry Gou , Sean Marett , Chung Jung Feng , Ugur Sabin , Hon Hai Precision Industry Co , National Taiwan University Cancer Center , Facebook , Biotech Corp , Yonglin Healthcare Foundation , Hon Hai Precision Industry , Retain Biotech , East Asian ,